Containment Level 3 (CL3) for Tuberculosis research
The RI MUHC has a CL3 (also known as Biosafety Level 3 or BSL3) Facility for TB research that meets highest safety standards defined by Canadian guidelines (PHAC and others). Work carried out in this Facility includes all experimental procedures where there is manipulation of live Mycobacterium tuberculosis. The Facility is available to RI MUHC researchers, affiliated researchers/collaborators and external researchers working on tuberculosis. All work to be carried out in the CL3 Lab must follow the established SOPs, as defined in the Facility's SOP manual.
The CL3 Facility comprises one room for bacterial manipulation and an adjoining room for experiments. Because work done in the RI MUHC CL3 lab must follow strict adherence to procedure, once a set of investigations is approved, the facility manager will oversee training and provide both guidance to researchers and monitoring of experiments.
More information
For further information on the RI MUHC CL3, please contact Fiona McIntosh, Facility manager, at:
The Research Institute of the McGill University Health Centre
1650 Cedar Avenue, room RS1-111
Montreal, Quebec H3G 1A4
phone: 514-934-1934 Ext. 44619
fax: 514-934-8261
mail:fiona.mcintosh [at] gmail.com
